We Design Plants to Bring Quality to Life
Explore our plant-based growth factors
One Business, Becomes Two
Over the past year the management of ORF Genetics, has been working on a new vision and strategy for the company. The new strategy is based on the premises that the operation of ORF Genetics has progressed into two different paths that have enjoyed synergy over the years but are now facing greater opportunities in separate entities: BIOEFFECT with an independent operation for skin care products and ORF Genetics working independently on growth factors. Consequently, the operation has been split in two separate businesses.
Using plants to produce specialty proteins is called molecular farming. We have developed a unique expression system which uses barley grain as a vehicle for production of recombinant human and animal proteins. This has resulted in an extensive portfolio of recombinant proteins for stem cell technology research, skincare, biopharma, and the cultured meat market.
Horizon 2020 - CCMeat Project
In the year 2020 ORF Genetics received a 2,5 million € grant from the Horizon Europe program of the European Union to partially fund the R&D project, CCMeat, which involves developing a new product line of growth factors, MESOkine, and scaling up their production for use in the production of Cell Cultured Meat (CCM). At the same time, the project aims to reduce the production cost of the growth factors to the level required by CCM companies to produce cell-cultured meat at a cost comparable to or lower than conventional meat.
By 2030, the MESOkine line will reach prices and scales of GFs allowing the production of cell-cultured meat at production costs in a similar range as conventionally produced meat in the scale of millions of tons of meat – truly a paradigm shift for the CCM industry. As the demand for meat continues to grow, this innovation will have a profound impact on our planet, enabling CCM to avert many of the negative consequences of conventional meat production. The planet needs the solution of the CCM companies and they need ours.